Article
Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis
3 Dec 2015
Abstract excerpt
Neuroblastoma (NB) is the most common extracranial childhood tumor classified in five stages (1, 2, 3, 4 and 4S), two of which (3 and 4) identify chemotherapy-resistant, highly aggressive disease. High-risk NB frequently displays MYCN amplification, mutations in ALK and ATRX, and genomic rearrangements in TERT genes. These NB subtypes are also characterized by reduced susceptibility to programmed cell death...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
